Market Tracker

12/19 6:05pm ET

Myriad Genetics Inc (NASDAQ:MYGN)

36.42
Data as of Dec 19
 +0.85 / +2.39%
Today’s Change
20.02
Today|||52-Week Range
42.50
+73.59%
Year-to-Date

Today’s Trading

Previous close35.57
Today’s open35.57
Day’s range35.05 - 36.96
Volume1,365,939
Average volume (3 months)764,071
Market cap$2.7B
Dividend yield--
Data as of 3:59pm ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)+27.12%
Earnings growth (this year)-24.47%
Earnings growth (next 5 years)+14.95%
Revenue growth (last year)+26.92%
P/E ratio20.5
Price/Sales3.79
Price/Book3.72

Competitors

 Today’s
change
Today’s
% change
--Cosmo Pharmaceutical...-11.95-6.38%
WXWuxi Pharmatech Caym...+1.06+3.08%
IPXLImpax Laboratories I...+0.54+1.74%
MNKDMannkind Corp-0.05-0.92%
Data as of 4:14pm ET, 12/19/2014

Financials

Next reporting dateFebruary 3, 2015
EPS forecast (this quarter)$0.35
Annual revenue (last year)$778.2M
Annual profit (last year)$176.2M
Net profit margin22.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Peter D. Meldrum
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts